News|Articles|August 1, 2023
Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia
Author(s)Mikart
Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
